Previously named Accelrys, it is a wholly owned subsidiary of Dassault Systèmes after an April 2014 acquisition[1] and has been renamed BIOVIA.
[9] In January 2012, Accelrys acquired VelQuest, a maker of pharmaceutical and medical device-related software, for $35 million in cash.
[10] In May 2012, Accelrys purchased Hit Explorer Operating System (HEOS) - a SaaS system that provides groups with project information in the cloud and access to biological assay results, analytics, chemical registration and pharmacokinetics data - from Scynexis.
[13] In January 2013, Accelrys acquired Swiss biosciences systems integrator Vialis AG for $5 million in cash.
[13] In September 2013, Accelrys acquired Environmental Health & Safety (EH&S) compliance provider ChemSW.